INVACARE CORPORATION (NYSE:IVC) Files An 8-K Regulation FD DisclosureItem 7.01.Regulation FD Disclosure.
On July 25, 2017, Invacare Corporation (the “Company”) issued a press release announcing that it has received notice from the United States Food and Drug Administration (“FDA”) that the Company has successfully satisfied FDA’s requirements under the consent decree to resume full operations at the Company’s Corporate and Taylor Street manufacturing facility in Elyria, Ohio. The company is now able to produce and sell all products made in the Taylor Street facility without the previous restrictions under the consent decree, which has been in effect since December 21, 2012.
The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01.Financial Statements and Exhibits.
|
(d) Exhibits. |
|
|
Exhibit Number |
Description of Exhibit |
|
99.1 |
Press Release, dated July 25, 2017. |
INVACARE CORP ExhibitEX-99.1 2 july252017exhibit.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 NEWS RELEASECONTACT:Lara Mahoney 440-329-6393INVACARE REACHES NEW CONSENT DECREE MILESTONE FDA Lifts All Consent Decree Restrictions on Production and Sales at the Company’s Taylor Street Wheelchair Manufacturing Facility in Elyria,…To view the full exhibit click here
About INVACARE CORPORATION (NYSE:IVC)
Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company manufactures and distributes three product categories: mobility and seating, lifestyle and respiratory therapy. It provides medical device solutions for congenital (cerebral palsy, muscular dystrophy and spina bifida), acquired (stroke, spinal cord injury, traumatic brain injury, post-acute recovery and pressure ulcers) and degenerative (amyotrophic lateral sclerosis, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly and bariatric) ailments. The Company sells its products to home medical equipment providers with retail and e-commerce channels, residential living operators, distributors and government health services.
